Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Clinical experience with FK 506].

T E Starzl, K Abu-Elmagd, J J Fung

    Presse Medicale (Paris, France : 1983)
    |November 27, 1991
    PubMed
    Summary

    FK 506 is a potent immunosuppressive drug that enhances transplant survival and enables new transplant possibilities. It also offers potential for treating autoimmune diseases and advancing understanding of cellular signaling pathways.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Impact of Steroids on Natural Killer Cells Against Cytotoxicity and Hepatitis C Virus Replication.

    Transplantation proceedings·2017
    Same author

    A Case Report of Severe Hepatic Artery Vasospasm Induced by Hepatic Arterial Buffer Response After Liver Transplantation.

    Transplantation proceedings·2016
    Same author

    Extra-anatomical Meso-portal Venous Jump Graft Repair for Early Portal Vein Thrombosis After Liver Transplant in an Infant With a Hypoplastic Portal Vein: A Case Report.

    Transplantation proceedings·2016
    Same author

    Liver xenotransplantation.

    Surgical technology international·2015
    Same author

    Liver, pancreas and kidney transplantation for the treatment of Wolcott-Rallison syndrome.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
    Same author

    The miracle of liver transplantation.

    The British journal of surgery·2013

    Area of Science:

    • Immunology and Transplant Medicine
    • Pharmacology
    • Cell Biology

    Background:

    • FK 506 (Tacrolimus) is a powerful immunosuppressive agent.
    • Current immunosuppressive therapies have limitations in efficacy and application.

    Discussion:

    • FK 506 demonstrates potential to significantly improve patient survival rates post-transplantation.
    • Its efficacy may extend to previously impractical transplantation procedures.
    • FK 506 offers a therapeutic avenue for severe autoimmune diseases.
    • Research with FK 506 can deepen the understanding of fundamental biological processes, particularly signal transduction.

    Key Insights:

    • FK 506 offers superior immunosuppression compared to existing agents.
    • The drug broadens the scope of feasible organ and tissue transplantation.
    • FK 506 presents a novel approach for managing autoimmune conditions.
    • Its mechanism provides insights into cellular signaling pathways.

    Outlook:

    • Further clinical trials are warranted to establish FK 506's full potential in transplantation and autoimmune disease treatment.
    • Continued research into FK 506's molecular mechanisms will illuminate basic cell biology.
    • Development of FK 506-based therapies could revolutionize immunosuppressive treatment paradigms.

    Related Experiment Videos